journal article·2019-12-04Open access

Using CuO nanoparticles and hyperthermia in radiotherapy of MCF-7 cell line: synergistic effect in cancer therapy

Hadi Esmaeili Govarchin Ghaleh, Leila Zarei, Bahman Mansori Motlagh, Nasrollah Jabbari

Abstract

The aim of this paper was examining the combined impacts of CuO nanoparticles (CuO NPs), hyperthermia (H), and irradiation (R) on an increment of MCF-7 cells. The MTT assay was employed to assess the antiproliferative effects of CuO NPs (25, 50, and 100 μg/ml), hyperthermia (41 °C for 1 h), and irradiation (200 cGy). Moreover, the perniciousness was estimated through the survival capability of cells, and apoptosis, ROS production, and levels of caspase-3, -8 and -9 proteins were determined. A significant (p < .01) decrease in proliferation index (0.124 ± 0.021), a significant (p < .01) increase in apoptosis (42% ± 1.54) of MCF7 cells, a significant (p < .03) increase in ROS formation (32.16 ± 1.9) and a significant (p < .01) increase in LDH release (33.28 ± 1.56) were recorded in the adjacency of MCF-7 cells by a combination of CuO NPs (100 µg/ml) and R + H compared to control and other treatments. The activities of caspase-3 (0.33 ± 0.014) and caspase-9 (0.389 ± 0.019) also increased significantly (p < .05). However, caspase-8 showed no significant changes in its activity (p = .065). Based on these observations, a combination of CuO NPs, hyperthermia, and irradiation could suppress the growth of MCF-7 cells and evoke cell apoptosis via mitochondrial membrane potential.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Applied Virology Research Center, Baqiyatallah University of Medical Sciences

Solid Tumor Research Center, Urmia University of Medical Sciences

References (44)

Show source-provided references
1. 10.1080/21691401.2017.137593710.1080/21691401.2017.1375937 ↗
2. Zhang X, Liu Z, Lou Z, et al. Radiosensitivity enhancement of Fe3O4@Ag nanoparticles on human glioblastoma cells. Artif Cells Nanomed Biotechnol. 2018;3:1–10.
3. 10.1080/21691401.2017.135430210.1080/21691401.2017.1354302 ↗
4. Liu Z, Tan H, Zhang X, et al. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells. Artif Cells Nanomed Biotechnol. 2018;11:1–9.
5. 10.1016/j.surg.2010.05.00610.1016/j.surg.2010.05.006 ↗
6. 10.1007/s12282-013-0496-910.1007/s12282-013-0496-9 ↗
7. 10.3109/21691401.2014.97523710.3109/21691401.2014.975237 ↗
8. 10.1016/j.jconrel.2014.12.03010.1016/j.jconrel.2014.12.030 ↗
9. 10.1038/s41598-017-07753-010.1038/s41598-017-07753-0 ↗
10. 10.1038/s41598-018-32480-510.1038/s41598-018-32480-5 ↗
11. Aparna Y, Venkateswara Rao K, Srinivasa Subbarao P. Preparation and Characterization of CuO Nanoparticles by Novel Sol-Gel Technique. J Nano-Electron Phys. 2012;4:3005–3008.
12. 10.4103/1011-4564.18889910.4103/1011-4564.188899 ↗
13. 10.2174/138920021966618012914175710.2174/1389200219666180129141757 ↗
14. Ahmed K, Zaidi SF. Treating cancer with heat: hyperthermia as promising strategy to enhance apoptosis. J Pak Med Assoc. 2013;63:504–508.
15. 10.3109/0265673100360174510.3109/02656731003601745 ↗
16. 10.3109/0265673090341337510.3109/02656730903413375 ↗
17. 10.1016/j.ejphar.2013.11.03110.1016/j.ejphar.2013.11.031 ↗
18. 10.1021/acs.molpharmaceut.5b0030410.1021/acs.molpharmaceut.5b00304 ↗
19. 10.4103/1319-3767.12947410.4103/1319-3767.129474 ↗
20. 10.1155/2013/51723710.1155/2013/517237 ↗
21. 10.1080/21691401.2018.145753710.1080/21691401.2018.1457537 ↗
22. 10.1080/21691401.2017.134794110.1080/21691401.2017.1347941 ↗
23. Shafagh M, Rahmani F, Delirezh N. CuO nanoparticles induce cytotoxicity and apoptosis in human K562 cancer cell line via mitochondrial pathway, through reactive oxygen species and P53. Iran J Basic Med Sci. 2015;18:993–1000.
24. 10.1073/pnas.130580411010.1073/pnas.1305804110 ↗
25. 10.1371/journal.pone.018863910.1371/journal.pone.0188639 ↗
26. 10.4155/tde.11.7210.4155/tde.11.72 ↗
27. 10.3163/1536-5050.102.4.01710.3163/1536-5050.102.4.017 ↗
28. 10.1007/s12011-014-9972-010.1007/s12011-014-9972-0 ↗
29. 10.1371/journal.pone.008797910.1371/journal.pone.0087979 ↗
30. 10.3109/02656736.2011.58736310.3109/02656736.2011.587363 ↗
31. 10.5301/RU.2013.1129610.5301/RU.2013.11296 ↗
32. 10.1016/j.radonc.2010.10.02010.1016/j.radonc.2010.10.020 ↗
33. 10.3892/ijo.2013.194610.3892/ijo.2013.1946 ↗
34. 10.1038/cdd.2016.2610.1038/cdd.2016.26 ↗
35. 10.3390/ma512285010.3390/ma5122850 ↗
36. 10.1002/etc.282610.1002/etc.2826 ↗
37. 10.1016/j.jhazmat.2011.09.09410.1016/j.jhazmat.2011.09.094 ↗
38. 10.4236/jct.2015.61009710.4236/jct.2015.610097 ↗
39. 10.1016/j.fct.2012.01.01710.1016/j.fct.2012.01.017 ↗
40. 10.3390/nano807053910.3390/nano8070539 ↗
41. 10.1007/s00204-012-0925-010.1007/s00204-012-0925-0 ↗
42. 10.1186/2049-3002-2-1610.1186/2049-3002-2-16 ↗
43. 10.1016/j.jep.2011.07.05610.1016/j.jep.2011.07.056 ↗
44. 10.15171/apb.2015.04910.15171/apb.2015.049 ↗